In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in ...

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Kidney Transplant Rejection ...

Cigna Group (CI) filed a lawsuit against Bristol Myers Squibb (BMY), accusing the pharmaceutical gia PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...

Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over ...

Discover 23 high-dividend stocks that outshine treasuries! Learn why growing dividends signal financial strength and explore ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Cambridge, Massachusetts-based Nuvalent has reported the results of its phase 1/2 ARROS-1 trial of zidesamtinib in previously ...

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

As China's biotech sector matures, companies are striving to reconcile their bold innovation goals with a healthcare system ...